Scholarlink

The development of Artificial Intelligence (AI) has significantly impacted the medical field, including the management of cholecystectomies and hepato-pancreato-biliary (HPB) surgery. In this field, AI can facilitate the discovery of non-parametric associations, supporting physicians in preoperative evaluation, providing intraoperative support, and predicting personalized postoperative outcomes. Preoperative applications include patient selection, radiomics, and predictive models for treatment allocation. Intraoperative support is enhanced through visual AI, which aids in anatomical structure identification and surgical navigation. Postoperatively, AI models can predict personalized patient outcomes based on comprehensive data analysis, contributing to precision medicine. Improvements and standardization of these tools are still needed. However, their integration into clinical practice has the potential to revolutionize the management of gallbladder and HPB diseases, offering more accurate evaluations, decision-making support, and personalized treatment plans.

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Managing Difficult Cholecystectomies and Hepatobiliary Procedures with AI

  • 章节

  • 发表日期：

    2026年

查看全文
  • Marcello Di Martino,
  • Simone Famularo,
  • Marco Nicolazzi,
  • Emanuele Tessitore,
  • Matteo Donadon

摘要

The development of Artificial Intelligence (AI) has significantly impacted the medical field, including the management of cholecystectomies and hepato-pancreato-biliary (HPB) surgery. In this field, AI can facilitate the discovery of non-parametric associations, supporting physicians in preoperative evaluation, providing intraoperative support, and predicting personalized postoperative outcomes. Preoperative applications include patient selection, radiomics, and predictive models for treatment allocation. Intraoperative support is enhanced through visual AI, which aids in anatomical structure identification and surgical navigation. Postoperatively, AI models can predict personalized patient outcomes based on comprehensive data analysis, contributing to precision medicine. Improvements and standardization of these tools are still needed. However, their integration into clinical practice has the potential to revolutionize the management of gallbladder and HPB diseases, offering more accurate evaluations, decision-making support, and personalized treatment plans.